{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:38:35Z","timestamp":1784864315395,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA049530"],"award-info":[{"award-number":["R21DA049530"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.brainresbull.2022.01.020","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T23:14:54Z","timestamp":1643843694000},"page":"157-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting"],"prefix":"10.1016","volume":"181","author":[{"given":"Gabriele","family":"Floris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Scheggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Pes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bortolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.brainresbull.2022.01.020_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson\u2019s disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"issue":"7","key":"10.1016\/j.brainresbull.2022.01.020_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/phar.1612","article-title":"Persistent sexual dysfunction and suicidal ideation in young men treated with low-dose finasteride: a pharmacovigilance study","volume":"35","author":"Ali","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.brainresbull.2022.01.020_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/09513590312331290328","article-title":"Low-dose (2.5 mg\/day) finasteride treatment in hirsutism","volume":"17","author":"Bayram","year":"2003","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"issue":"11","key":"10.1016\/j.brainresbull.2022.01.020_bib4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.27181","article-title":"Impulse control disorders in advanced Parkinson\u2019s disease with dyskinesia: The ALTHEA study","volume":"32","author":"Biundo","year":"2017","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"13","key":"10.1016\/j.brainresbull.2022.01.020_bib5","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","article-title":"Antipsychotic-like properties of 5-alpha-reductase inhibitors","volume":"33","author":"Bortolato","year":"2008","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"13","key":"10.1016\/j.brainresbull.2022.01.020_bib6","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1038\/npp.2009.118","article-title":"Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice","volume":"34","author":"Bortolato","year":"2009","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e3182549c2a","article-title":"finasteride attenuates pathological gambling in patients with Parkinson disease","volume":"32","author":"Bortolato","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.brainresbull.2022.01.020_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143990","article-title":"The 5\u03b1-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder","volume":"131","author":"Boss\u00e9","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10826089509048726","article-title":"A comparison of pathological gamblers to alcoholics and cocaine misusers on impulsivity, sensation seeking, and craving","volume":"30","author":"Castellani","year":"1995","journal-title":"Int. J. Addict."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","article-title":"Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling","volume":"39","author":"Cilia","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.01.020_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson\u2019s disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.brainresbull.2022.01.020_bib12","first-page":"360","article-title":"Pathological gambling in hospitalized substance abusing veterans","volume":"57","author":"Daghestani","year":"1996","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.brainresbull.2022.01.020_bib13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.psyneuen.2011.09.018","article-title":"Inhibition of 5\u03b1-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation","volume":"37","author":"Devoto","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41398-019-0674-4","article-title":"Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice","volume":"9","author":"Dieterich","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41398-021-01250-9","article-title":"Chronic non-discriminatory social defeat stress reduces effort-related motivated behaviors in male and female mice","volume":"11","author":"Dieterich","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainresbull.2022.01.020_bib16","article-title":"Post-finasteride syndrome: an emerging clinical problem","volume":"12","author":"Diviccaro","year":"2019","journal-title":"Neurobiol. Stress"},{"issue":"9","key":"10.1016\/j.brainresbull.2022.01.020_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson\u2019s disease","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JCP.0000000000000634","article-title":"Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study","volume":"37","author":"Etminan","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2018.09.018","article-title":"5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction","volume":"121","author":"Fanni","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.637074","article-title":"\u201cHimalayan bridge\u201d: a new unstable suspended bridge to investigate rodents\u2019 venturesome behavior","volume":"15","author":"Festucci","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"8","key":"10.1016\/j.brainresbull.2022.01.020_bib22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1530-0277.2008.00718.x","article-title":"Inhibition of 5alpha-reduced steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL\/6J mice","volume":"32","author":"Ford","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuropharm.2018.05.013","article-title":"Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats","volume":"147","author":"Frau","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.01.020_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.psyneuen.2012.07.014","article-title":"Inhibition of 5\u03b1-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL\/6 mice","volume":"38","author":"Frau","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.schres.2015.04.044","article-title":"Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress","volume":"168","author":"Frau","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2015.09.014","article-title":"The neurosteroidogenic enzyme 5\u03b1-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating","volume":"63","author":"Frau","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.brainresbull.2022.01.020_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2017.01.012","article-title":"The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson\u2019s disease","volume":"291","author":"Frau","year":"2017","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.brainresbull.2022.01.020_bib28","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/npp.2017.13","article-title":"The neurosteroidogenic enzyme 5\u03b1-reductase mediates psychotic-like complications of sleep deprivation","volume":"42","author":"Frau","year":"2017","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1557988314538445","article-title":"Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms","volume":"9","author":"Ganzer","year":"2015","journal-title":"Am. J. Men. \u2019S. Health"},{"issue":"11","key":"10.1016\/j.brainresbull.2022.01.020_bib30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/biom9110749","article-title":"The steroidogenesis inhibitor finasteride reduces the response to both stressful and rewarding stimuli","volume":"9","author":"Godar","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.brainresbull.2022.01.020_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.01.028","article-title":"Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation","volume":"159","author":"Godar","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","article-title":"Dopamine agonists and impulse control disorders: a complex association","volume":"41","author":"Grall-Bronnec","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib33","first-page":"l5047","article-title":"Post-finasteride syndrome","volume":"366","author":"Gray","year":"2019","journal-title":"BMJ Clin. Res. Ed."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.01.020_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/ijd.14370","article-title":"The efficacy and use of finasteride in women: a systematic review","volume":"58","author":"Hu","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/DDDT.S240615","article-title":"finasteride and its potential for the treatment of female pattern hair loss: evidence to date","volume":"14","author":"Iamsumang","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"9","key":"10.1016\/j.brainresbull.2022.01.020_bib36","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4088\/JCP.12m07887","article-title":"Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects","volume":"73","author":"Irwig","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227128","article-title":"What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study","volume":"15","author":"Jeon","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.brainresbull.2022.01.020_bib38","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/add.14397","article-title":"Probability discounting and gambling: a meta-analysis","volume":"113","author":"Kyonka","year":"2018","journal-title":"Addiction"},{"issue":"32","key":"10.1016\/j.brainresbull.2022.01.020_bib39","doi-asserted-by":"crossref","first-page":"29979","DOI":"10.1074\/jbc.M303242200","article-title":"Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2","volume":"278","author":"Laurine","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.01.020_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bpa.12253","article-title":"Molecular, neurochemical, and behavioral hallmarks of reserpine as a model for Parkinson\u2019s disease: new perspectives to a long-standing model","volume":"25","author":"Le\u00e3o","year":"2015","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.49.1.162","article-title":"Clinical evaluation of pramipexole in advanced Parkinson\u2019s disease: results of a double-blind, placebo-controlled, parallel-group study","volume":"49","author":"Lieberman","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.brainresbull.2022.01.020_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1037\/a0016806","article-title":"Pathological gamblers discount probabilistic rewards less steeply than matched controls","volume":"17","author":"Madden","year":"2009","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/a0019244","article-title":"Effects of pramipexole on impulsive choice in male wistar rats","volume":"18","author":"Madden","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib44","first-page":"297","article-title":"Pathological gambling: a behavioral addiction","volume":"15","author":"Mann","year":"2016","journal-title":"World Psychiatry. Off. J. World Psychiatr. Assoc. WPA"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.01.020_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archgenpsychiatry.2011.1552","article-title":"Altered neural reward representations in pathological gamblers revealed by delay and probability discounting","volume":"69","author":"Miedl","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0922-4106(95)90013-6","article-title":"Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors","volume":"290","author":"Mierau","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.01.020_bib47","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.52.5.938","article-title":"Restless legs syndrome improved by pramipexole: a double-blind randomized trial","volume":"52","author":"Montplaisir","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.brainresbull.2022.01.020_bib48","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib49","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/s41598-017-03649-1","article-title":"Allopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models","volume":"7","author":"Mosher","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.01.020_bib50","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1073\/pnas.97.7.3579","article-title":"Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly","volume":"97","author":"Murakami","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.brainresbull.2022.01.020_bib51","doi-asserted-by":"crossref","first-page":"11271","DOI":"10.1073\/pnas.91.23.11271","article-title":"Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain","volume":"91","author":"Murray","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2020.3385","article-title":"Investigation of suicidality and psychological adverse events in patients treated with finasteride","volume":"157","author":"Nguyen","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"8","key":"10.1016\/j.brainresbull.2022.01.020_bib53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40266-013-0090-z","article-title":"Dopamine agonist withdrawal syndrome: implications for patient care","volume":"30","author":"Nirenberg","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.brainresbull.2022.01.020_bib54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.euroneuro.2020.01.005","article-title":"The adverse effects of pramipexole on probability discounting are not reversed by acute D2 or D3 receptor antagonism","volume":"32","author":"Orr\u00f9","year":"2020","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2013.05.042","article-title":"Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area","volume":"252","author":"Ouachikh","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.01.020_bib56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainresbull.2022.01.020_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2016.11.014","article-title":"Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release","volume":"114","author":"Pes","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.01.020_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(00)00188-5","article-title":"Substance abuse, pathological gambling, and impulsiveness","volume":"63","author":"Petry","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091151","article-title":"Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway","volume":"9","author":"Purves-Tyson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2022.01.020_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6904-6-7","article-title":"finasteride induced depression: a prospective study","volume":"6","author":"Rahimi-Ardabili","year":"2006","journal-title":"BMC Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainresbull.2022.01.020_bib61","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.23147","article-title":"Decreased ventral striatal activity with impulse control disorders in Parkinson\u2019s disease","volume":"25","author":"Rao","year":"2010","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"6","key":"10.1016\/j.brainresbull.2022.01.020_bib62","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/npp.2011.325","article-title":"Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson\u2019s disease and controls","volume":"37","author":"Rokosik","year":"2012","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"Pt B","key":"10.1016\/j.brainresbull.2022.01.020_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jad.2020.11.075","article-title":"Depression is Associated with Impulse-compulsive Behaviors in Parkinson\u2019s disease","volume":"280","author":"Santos-Garc\u00eda","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.brainresbull.2022.01.020_bib64","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","article-title":"A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability","volume":"15","author":"Schuirmann","year":"1987","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.01.020_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/syn.21805","article-title":"Parkinson\u2019s disease treatment may cause impulse-control disorder via dopamine D3 receptors","volume":"69","author":"Seeman","year":"2015","journal-title":"Synapse"},{"issue":"13","key":"10.1016\/j.brainresbull.2022.01.020_bib66","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3109\/10826089809059340","article-title":"Pathological gambling and substance misuse: a review of the literature","volume":"33","author":"Spunt","year":"1998","journal-title":"Subst. Use Misuse"},{"issue":"3","key":"10.1016\/j.brainresbull.2022.01.020_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11154-015-9319-y","article-title":"Adverse effects of 5\u03b1-reductase inhibitors: what do we know, don\u2019t know, and need to know?","volume":"16","author":"Traish","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.01.020_bib68","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1210\/jcem.84.4.5591","article-title":"A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism","volume":"84","author":"Venturoli","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.brainresbull.2022.01.020_bib69","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/S1353-8020(11)70026-8","article-title":"Impulse control disorders in Parkinson\u2019s disease","volume":"18","author":"Vilas","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.01.020_bib70","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.01.020_bib71","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.01.020_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12588","article-title":"Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg\/day in women with female pattern hair loss","volume":"31","author":"Won","year":"2018","journal-title":"Dermatol. Ther."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.01.020_bib73","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hbm.21067","article-title":"Pramipexole modulates the neural network of reward anticipation","volume":"32","author":"Ye","year":"2011","journal-title":"Hum. brain Mapp."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:49:01Z","timestamp":1759783741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923022000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":73,"alternative-id":["S0361923022000326"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.01.020","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}